Saito Hiroaki, Kono Yusuke, Murakami Yuki, Shishido Yuji, Kuroda Hirohiko, Matsunaga Tomoyuki, Fukumoto Yoji, Osaki Tomohiro, Ashida Keigo, Fujiwara Yoshiyuki
Division of Surgical Oncology, Department of Surgery, Faculty of Medicine, School of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
World J Surg. 2018 Jun;42(6):1819-1825. doi: 10.1007/s00268-017-4400-1.
The ratio of C-reactive protein to albumin (CRP/Alb) is a biochemical marker of systemic inflammatory response and has been associated with poor survival in cancer. This study retrospectively investigated the relationship between the CRP/Alb ratio and prognosis in gastric cancer patients.
This study enrolled 453 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery.
A statistically significant weak correlation was observed between CRP/Alb ratio and neutrophil/lymphocyte ratio (NLR) (r = 0.19; P < 0.0001). There were statistically significant correlations between high CRP/Alb ratio and age (P = 0.0004), tumor size (P = 0.02), depth of invasion (P = 0.012), and lymph node metastasis (P = 0.022). A high NLR was significantly correlated with age (P = 0.0027), tumor size (P = 0.0006), depth of invasion (P < 0.0001), lymphatic involvement (P = 0.0031), venous involvement (P = 0.0022), and stage of disease (P = 0.0024). Based on results by receiver operating characteristic analysis, patients were divided as follows: CRP/Alb ratio ≥ 0.0232 (CAR), CRP/Alb ratio < 0.0232 (CAR), NLR ≥ 2.43 (NLR), and NLR < 2.43 (NLR). Five-year survival rates of patients with both CAR and NLR, either CAR or NLR, and both CAR and NLR were 59.6, 75.8, and 87.5%, respectively, with statistically significant differences (P < 0.0001). Multivariate analysis revealed that the combination of CRP/Alb ratio and NLR was an independent prognostic indicator.
The combination of CRP/Alb ratio and NLR may be useful in predicting prognosis in gastric cancer patients.
C反应蛋白与白蛋白比值(CRP/Alb)是全身炎症反应的生化标志物,与癌症患者的不良生存相关。本研究回顾性调查了CRP/Alb比值与胃癌患者预后的关系。
本研究纳入了453例经组织病理学诊断为胃腺癌并接受根治性手术的患者。
观察到CRP/Alb比值与中性粒细胞/淋巴细胞比值(NLR)之间存在统计学上显著的弱相关性(r = 0.19;P < 0.0001)。高CRP/Alb比值与年龄(P = 0.0004)、肿瘤大小(P = 0.02)、浸润深度(P = 0.012)和淋巴结转移(P = 0.022)之间存在统计学上显著的相关性。高NLR与年龄(P = 0.0027)、肿瘤大小(P = 0.0006)、浸润深度(P < 0.0001)、淋巴管受累(P = 0.0031)、静脉受累(P = 0.0022)和疾病分期(P = 0.0024)显著相关。根据受试者工作特征分析结果,将患者分为以下几组:CRP/Alb比值≥0.0232(CAR)、CRP/Alb比值<0.0232(CAR)、NLR≥2.43(NLR)和NLR<2.43(NLR)。CAR和NLR均高、CAR或NLR高以及CAR和NLR均低的患者的五年生存率分别为59.6%、75.8%和87.5%,差异有统计学意义(P < 0.0001)。多变量分析显示,CRP/Alb比值和NLR的组合是一个独立的预后指标。
CRP/Alb比值和NLR的组合可能有助于预测胃癌患者的预后。